BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9195850)

  • 1. Exploration of novel strategies to enhance monoclonal antibodies targeting.
    Khawli LA; Epstein AL
    Q J Nucl Med; 1997 Mar; 41(1):25-35. PubMed ID: 9195850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor pretargeting for radioimmunodetection and radioimmunotherapy.
    Zhu H; Jain RK; Baxter LT
    J Nucl Med; 1998 Jan; 39(1):65-76. PubMed ID: 9443740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumor targeting by combined use of two antitenascin antibodies.
    Petronzelli F; Pelliccia A; Anastasi AM; D'Alessio V; Albertoni C; Rosi A; Leoni B; De Angelis C; Paganelli G; Palombo G; Dani M; Carminati P; De Santis R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7137s-7145s. PubMed ID: 16203813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody pretargeting advances cancer radioimmunodetection and radioimmunotherapy.
    Goldenberg DM; Sharkey RM; Paganelli G; Barbet J; Chatal JF
    J Clin Oncol; 2006 Feb; 24(5):823-34. PubMed ID: 16380412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunodiagnosis and therapy.
    Verhaar-Langereis MJ; Zonnenberg BA; de Klerk JM; Blijham GH
    Cancer Treat Rev; 2000 Feb; 26(1):3-10. PubMed ID: 10660488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radioimmunotargeting: diagnosis and therapeutic use].
    Vuillez JP
    Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control of radiolabeled monoclonal antibodies.
    Khazaeli MB
    Cancer Biother Radiopharm; 2000 Dec; 15(6):529-30. PubMed ID: 11190485
    [No Abstract]   [Full Text] [Related]  

  • 8. [Monoclonal antibodies. An approach to diagnosis and treatment of micrometastases].
    Bier H
    HNO; 1994 May; 42(5):255-6. PubMed ID: 8050912
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
    Fleckenstein G; Osmers R; Puchta J
    Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Principles of radioimmunotherapy for hematologists and oncologists.
    Press OW; Rasey J
    Semin Oncol; 2000 Dec; 27(6 Suppl 12):62-73. PubMed ID: 11226002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents.
    Pauwels EK; Erba P
    Drug News Perspect; 2007 Mar; 20(2):87-93. PubMed ID: 17440631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoscintigraphy and radioimmunotherapy in Cuba: experiences with labeled monoclonal antibodies for cancer diagnosis and treatment (1993-2013).
    Peña Y; Perera A; Batista JF
    MEDICC Rev; 2014; 16(3-4):55-60. PubMed ID: 25208121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection and radioimmunotherapy of head and neck cancer.
    Börjesson PK; Postema EJ; de Bree R; Roos JC; Leemans CR; Kairemo KJ; van Dongen GA
    Oral Oncol; 2004 Sep; 40(8):761-72. PubMed ID: 15288829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved targeting of radiolabeled streptavidin in tumors pretargeted with biotinylated monoclonal antibodies through an avidin chase.
    Yao Z; Zhang M; Kobayashi H; Sakahara H; Nakada H; Yamashina I; Konishi J
    J Nucl Med; 1995 May; 36(5):837-41. PubMed ID: 7738661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition based hormonal 95kDa monoclonal antibody on three human cancer cell lines for developing targeted radio-immuno-imaging and therapy.
    Bandopadhyaya GP; Arora G; Shukla J; Ghosh S
    Hell J Nucl Med; 2012; 15(2):108-13. PubMed ID: 22833856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
    Lindén O; Kurkus J; Garkavij M; Cavallin-Ståhl E; Ljungberg M; Nilsson R; Ohlsson T; Sandberg B; Strand SE; Tennvall J
    Cancer Biother Radiopharm; 2005 Aug; 20(4):457-66. PubMed ID: 16114994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunodetection of solid tumors. Future horizons and applications for radioimmunotherapy.
    McKearn TJ
    Cancer; 1993 Jun; 71(12 Suppl):4302-13. PubMed ID: 8508392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.
    England CG; Rui L; Cai W
    Eur J Nucl Med Mol Imaging; 2017 Mar; 44(3):517-532. PubMed ID: 27844106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.